Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

More articles from Journal club

  • Length of remdesivir treatment in patients with severe COVID-19
    Mariachiara Ippolito, Andrea Cortegiani
    Breathe Mar 2021, 17 (1) 200276; DOI: 10.1183/20734735.0276-2020
  • Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19
    Huseyin Arikan, Jeremy Cordingley
    Breathe Mar 2021, 17 (1) 200278; DOI: 10.1183/20734735.0278-2020
  • Using biomarkers to adjust corticosteroid dose in patients with severe asthma
    Thomas L. Jones
    Breathe Mar 2021, 17 (1) 200324; DOI: 10.1183/20734735.0324-2020
  • Does inhaled corticosteroid use affect the risk of COVID-19-related death?
    Alexander Jordan, Pradeesh Sivapalan, Jens-Ulrik Jensen
    Breathe Mar 2021, 17 (1) 200275; DOI: 10.1183/20734735.0275-2020
  • Efficacy and safety of once-daily single-inhaler triple therapy in patients with inadequately controlled asthma: the CAPTAIN trial
    Iñigo Ojanguren, María Florencia Pilia
    Breathe Mar 2021, 17 (1) 200279; DOI: 10.1183/20734735.0279-2020
  • Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
    Paolo Maria Leone, Luca Richeldi
    Breathe Dec 2020, 16 (4) 200223; DOI: 10.1183/20734735.0223-2020
  • Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
    Andrea Guariglia, Iona J. Davies, Nikolaos I. Kanellakis
    Breathe Dec 2020, 16 (4) 200204; DOI: 10.1183/20734735.0204-2020
  • Conservative versus interventional treatment for spontaneous pneumothorax
    Samantha L. Ennis, Claudia C. Dobler
    Breathe Sep 2020, 16 (3) 200171; DOI: 10.1183/20734735.0171-2020
  • Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need
    Amanda T. Goodwin, Gauri Saini
    Breathe Sep 2020, 16 (3) 200066; DOI: 10.1183/20734735.0066-2020
  • The adoption of nintedanib in systemic sclerosis: the SENSCIS study
    Teresa Bruni, Francesco Varone
    Breathe Jun 2020, 16 (2) 200005; DOI: 10.1183/20734735.0005-2020

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society